Revolutionising clinical practice for lung cancer in Asia

Dr. Ross Soo, Senior Consultant at Department of Haematology-Oncology (NUS, Singapore) explicates advances in Lung cancer treatment through immunotherapy and the development of more effective targeted therapies

Related Keywords

China ,Sweden ,United States ,Singapore ,National University Of Singapore ,Singapore General ,America ,Swedish ,Ross Soo ,Solange Peters ,Department Of Haematology ,Drug Administration ,Adjunct Senior Research ,Cancer Science Institute ,World Health Organisation ,National University Cancer Institute ,European Society For Medical Oncology ,Swedish Institute For Health Economics ,European Society ,Medical Oncology ,Virtual Oncology Week ,Senior Consultant ,Adjunct Senior Research Fellow ,National University ,Swedish Institute ,Health Economics ,United States Food ,Clinical Benefit Scale ,Project Orbis ,Dr Ross Soo ,Enior Consultant At Department Of Haematology Oncology Nus , ,